FACN

AcronymDefinition
FACNFellow of the American College of Nutrition
FACNForeign Agent Control Node
FACNFundación Argentina de Cl ca Neuropsiquiátrica
FACNFleet Air Coordination Net
FACNFunctional Assessment Completion Notice
FACNFunctional Assessment Conduct Notice
FACNForensic Assessment Center Network (diagnosing cases of child abuse and neglect in the state of Texas)
References in periodicals archive ?
Bioanalytical research company FutureCeuticals Inc reported on Tuesday the addition of Nagendra Rangavajla PhD, FACN as its chief science officer (CSO).
Key speakers will include William Davis, MD; Alessio Fasasno, MD; and David Perlmutter, MD, FACN, ABIHM.
Deanna Minich, PhD FACN, CNS is vice president, scientific affairs at Metagenics, Inc.
The Metagenics University webinar will be presented by Deanna Minich, PhD, FACN, CNS, Vice President of Scientific Affairs at Metagenics.
Deanna Minich, PhD, FACN, CNS, a mind-body-spirit nutritionist and author of four books on nutrition and wellness.
FACN, CNS, Navidea's Senior Vice President of Pharmaceutical Research and Clinical Development commented, "Further to results reported to the Sentinel Node Oncology Foundation and International Sentinel Lymph Node Working Group earlier this year, we are clarifying that these data represent not only a comparison of Lymphoseek to sulfur colloid but to sulfur colloid plus Vital Blue Dye.
Ingrid Kohlstadt, MD, MPH, FACPM, FACN Faculty Associate
Ingrid Kohlstadt, MD, MPH, FACN, FACPM, is the founder of INGRIDients Inc.
FACN CNS, Navidea's Senior Vice President of Pharmaceutical Research and Clinical Development, described, for the first time, a meta-analysis and pooled-data comparison of results from Navidea's prospective Phase 3 clinical trials of Lymphoseek in patients with breast cancer, to historical data on sulfur colloid from documents filed with FDA related to sulfur colloid labeling for breast cancer lymphatic mapping.
FACN, Navidea's Senior Vice President of Pharmaceutical Research and Clinical Development commented, "These data comprise the first presentation of Lymphoseek's potential utility in oral cancers.
The Clear Change Program is our most patient-friendly metabolic detoxification plan to date, providing science-based nutritional support to aid the body's natural processes for clearing the build-up of potentially harmful substances from poor dietary habits, environmental chemicals and other factors," said Deanna Minich, PhD, FACN, Vice President of Scientific Affairs at Metagenics.
Hyman to discuss innovative diagnostic and nutrigenomic treatment strategies will be guest speakers Bridget Briggs, MD and Deanna Minich, PhD, FACN, CNS, clinical nutritionist and Vice President of Scientific Affairs at Metagenics.